Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
study ends around

Description

Summary

VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients across three sites in Germany and the United States provide daily voice recordings via a mobile app for 12 weeks while continuing standard PA pressure monitoring and heart failure care. Voice data is analyzed retrospectively after study completion; no clinical decisions are based on voice analysis during the study. The primary endpoint is the sensitivity and specificity of the AI-based voice analysis in detecting PA pressure changes at defined thresholds.

Official Title

Voice Analysis Using Artificial Intelligence to Detect Changes in Pulmonary Arterial Pressure in Patients With Heart Failure and an Implanted Pressure Sensor

Details

Implanted PA pressure sensors enable early detection of heart failure decompensation but are costly and invasive. Fluid retention in heart failure may affect the vocal apparatus, producing measurable voice changes that could serve as a non-invasive alternative for monitoring pulmonary congestion.

Participants record daily voice samples consisting of sustained vowel sounds and a standardized reading passage via the Noah Labs mobile app. PA pressure readings are collected daily per standard care. Voice recordings and clinical data are analyzed retrospectively using classical machine learning and deep learning approaches. No additional clinical visits are required.

Keywords

Heart Failure, Daily Voice Recording

Eligibility

You can join if…

Open to people ages 18 years and up

  • Age 18 years or older
  • Successful implantation of a PA pressure sensor and monitored by a participating study center
  • Willingness to record a short predefined text daily for 3 months using a smartphone or tablet
  • Ability to comfortably read aloud the study passage in English or German
  • Written informed consent obtained

You CAN'T join if...

  • Pregnant, breastfeeding, or unwilling to practice birth control during participation
  • Condition that in the opinion of the investigator would compromise patient safety or data quality
  • Pathological voice changes due to surgery or injury
  • Planned invasive cardiac procedures during the study period
  • COPD requiring home oxygen therapy
  • Chronic kidney disease requiring dialysis
  • Cognitive dysfunction limiting ability to perform daily voice recording
  • Inability to read English or German
  • Physical inability to use the recording device

Locations

  • University of California, San Francisco (UCSF) accepting new patients
    San Francisco California 94143 United States
  • BG Klinikum Unfallkrankenhaus Berlin, Dept. of Cardiology completed
    Berlin State of Berlin 12683 Germany
  • University Hospital Frankfurt, Dept. of Cardiology and Angiology completed
    Frankfurt 60590 Germany

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Noah Labs
ID
NCT07443670
Study Type
Observational
Participants
Expecting 60 study participants
Last Updated